BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.36.4//EN
X-ORIGINAL-URL:https://oligotherapeutics.org/
X-WR-CALNAME:Oligonucleotide Therapeutics Society
X-WR-CALDESC:Oligonucleotide Therapeutics Society
X-WR-TIMEZONE:UTC
BEGIN:VTIMEZONE
TZID:UTC
X-LIC-LOCATION:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20261004T092810
END:STANDARD
END:VTIMEZONE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-6b1f4682a3003e2334a3a6bec0ec1977@oligotherapeutics.org
DTSTART;TZID=UTC:20220210T110000
DTEND;TZID=UTC:20220210T120000
DTSTAMP:20220203T035615Z
CREATED:20220203
LAST-MODIFIED:20220203
PRIORITY:5
SEQUENCE:0
TRANSP:OPAQUE
SUMMARY:A Perspective From Industry – A Conversation With Richard S. Geary, Ph.D. Executive Vice President, Chief Development Officer at Ionis Pharmaceuticals
DESCRIPTION:The OTS Webinar series is pleased to feature Dr. Richard Geary, the current President Elect, and the Executive Vice President, Chief Development Officer at Ionis Pharmaceuticals. For part of the webinar he will present some of his most recent research, and for the rest of the hour he is happy to answer your questions about science, working in industry, and more.\n
URL:http://oligotherapeutics.org/a-perspective-from-industry-a-conversation-with-richard-s-geary-ph-d-executive-vice-president-chief-development-officer-at-ionis-pharmaceuticals/
CATEGORIES:Society Events
ATTACH;FMTTYPE=image/webp:https://oligotherapeutics.org/wp-content/uploads/2021/06/OTS_Upcoming_Webinar.webp
END:VEVENT
END:VCALENDAR